Esomeprazole 20mg gastro-resistant capsules Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

esomeprazole 20mg gastro-resistant capsules

a a h pharmaceuticals ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg

Esomeprazole 20mg gastro-resistant capsules Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

esomeprazole 20mg gastro-resistant capsules

alliance healthcare (distribution) ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg

Esomeprazole 20mg gastro-resistant capsules Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

esomeprazole 20mg gastro-resistant capsules

waymade healthcare plc - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg

Esomeprazole 20mg gastro-resistant capsules Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

esomeprazole 20mg gastro-resistant capsules

sigma pharmaceuticals plc - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg

Esomeprazole 20mg gastro-resistant capsules Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

esomeprazole 20mg gastro-resistant capsules

mawdsley-brooks & company ltd - esomeprazole magnesium dihydrate - gastro-resistant capsule - 20mg

ESOMEPRAZOLE IV MYLAN esomeprazole 40 mg (as sodium) powder for injection vial Australia - angielski - Department of Health (Therapeutic Goods Administration)

esomeprazole iv mylan esomeprazole 40 mg (as sodium) powder for injection vial

medtas pty ltd - esomeprazole sodium, quantity: 42.5 mg (equivalent: esomeprazole, qty 40 mg) - injection, powder for - excipient ingredients: disodium edetate; sodium hydroxide; nitrogen - the short-term management of gastro-oesophageal reflux disease (gord) in patients with oesophagitis and/or severe symptoms of reflux as an alternative when oral therapy is inappropriate.,prevention of rebleeding in patients following therapeutic endoscopy for acute, bleeding gastric or duodenal ulcers.,short-term management in patients requiring continued non-steroidal anti-inflammatory drug (nsaid) therapy when oral therapy is inappropriate:,? healing of gastric ulcers associated with nsaid therapy ? prevention of gastric and duodenal ulcers associated with nsaid therapy, in patients at risk,esomeprazole iv mylan should be replaced with oral therapy as soon as practicable.